(7R,12Z,15Z,18Z,21Z,24Z,27Z)-4-Hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-3,5,8-trioxa-4-phosphatriaconta-12,15,18,21,24,27-hexaen-1-aminium 4-Oxide; 1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine; Palmitoyldocosahexaenoylphosphatidylcholine

Palmitoyldocosahexaenoyl phosphatidylcholine (PC-S) is a fatty acid with six double bonds. It has been shown to induce osteogenic genes in human macrophages and can be used as a potential therapeutic agent for the treatment of bone diseases. PC-S also has anti-inflammatory properties, which is due to its ability to inhibit secretory phospholipase A2 (sPLA2). PC-S is structurally similar to the polyunsaturated fatty acid linoleic acid and has been found to have reactive properties. PC-S may be used as an adjuvant therapy for cancer and other diseases, such as Alzheimer's disease. Clinical studies are currently being conducted.